POISE Trial: Perioperative Ischemic Evaluation Study
Phase 3
Terminated
- Conditions
- Cardiovascular Diseases
- Interventions
- Drug: Placebo
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2008-04-11
- Lead Sponsor
- Hamilton Health Sciences Corporation
- Target Recruit Count
- 8351
- Registration Number
- NCT00182039
- Locations
- 🇨🇦
McMaster University, Hamilton, Ontario, Canada
Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders
Phase 4
Terminated
- Conditions
- Phobia, SocialPanic DisorderAgoraphobiaObsessive-Compulsive DisorderMajor Depressive DisorderAnxiety Disorders
- Interventions
- Drug: Placebo
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2018-03-22
- Lead Sponsor
- Hamilton Health Sciences Corporation
- Target Recruit Count
- 170
- Registration Number
- NCT00182533
- Locations
- 🇨🇦
MacAnxiety Research Centre, Hamilton, Ontario, Canada
Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters
Phase 3
Completed
- Conditions
- ThrombosisEnd Stage Renal DiseaseBleeding
- Interventions
- Drug: placebo
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-06-17
- Lead Sponsor
- Hamilton Health Sciences Corporation
- Target Recruit Count
- 170
- Registration Number
- NCT00157651
- Locations
- 🇨🇦
St. Joseph's Healthcare, Hamilton, Ontario, Canada
Long Study - Longitudinal Thrombosis in End Stage Renal Disease
- Conditions
- ThrombosisBleedingEnd Stage Renal DiseaseCardiovascular Disease
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-06-17
- Lead Sponsor
- Hamilton Health Sciences Corporation
- Target Recruit Count
- 400
- Registration Number
- NCT00157664
- Locations
- 🇨🇦
St. Joseph's Hospital, Hamilton, Ontario, Canada
Integrating Family Medicine and Pharmacy to Advance Primary Care Therapeutics
Phase 4
Completed
- Conditions
- DiabetesHypertensionHyperlipidemiaConstipationPain
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2006-09-11
- Lead Sponsor
- Hamilton Health Sciences Corporation
- Target Recruit Count
- 1400
- Registration Number
- NCT00157638
- Locations
- 🇨🇦
University of Toronto, Toronto, Ontario, Canada
🇨🇦McMaster University, Hamilton, Ontario, Canada
🇨🇦University of Ottawa, Ottawa, Ontario, Canada
Quality of Life Among Breast Reduction Patients
Completed
- Conditions
- Breast Hypertrophy
- First Posted Date
- 2005-09-08
- Last Posted Date
- 2005-09-08
- Lead Sponsor
- Hamilton Health Sciences Corporation
- Target Recruit Count
- 52
- Registration Number
- NCT00149370
- Locations
- 🇨🇦
St. Joseph's Healthcare / McMaster University, Hamilton, Ontario, Canada
The Effects of Two Education Strategies About Insulin on Patient Preferences and Perceptions About Insulin Therapy
Phase 4
Completed
- Conditions
- Type 2 Diabetes
- First Posted Date
- 2005-09-08
- Last Posted Date
- 2006-09-11
- Lead Sponsor
- Hamilton Health Sciences Corporation
- Target Recruit Count
- 86
- Registration Number
- NCT00149331
- Locations
- 🇨🇦
Hamilton Health Sciences - Henderson Site, Hamilton, Ontario, Canada
Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT)
Completed
- Conditions
- Renal Insufficiency
- First Posted Date
- 2005-08-30
- Last Posted Date
- 2007-06-01
- Lead Sponsor
- Hamilton Health Sciences Corporation
- Target Recruit Count
- 140
- Registration Number
- NCT00138099
- Locations
- 🇨🇦
Ottawa General Hospital, Ottawa, Ontario, Canada
🇨🇦Ottawa Civic Hospital, Ottawa, Ontario, Canada
🇨🇦Hopital Maisonneuve Rosemont, Montreal, Quebec, Canada
HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)
Phase 4
- Conditions
- Cardiovascular DiseaseMyocardial InfarctionStrokeCancer
- First Posted Date
- 2005-04-01
- Last Posted Date
- 2005-09-20
- Lead Sponsor
- Hamilton Health Sciences Corporation
- Target Recruit Count
- 5000
- Registration Number
- NCT00106886
- Locations
- 🇨🇦
McMaster University and Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada
© Copyright 2025. All Rights Reserved by MedPath